Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Paroxysmal Nocturnal Hemoglobinuria
Related studies linked through entity extraction aliases.
To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
The International PNH Interest Group PNH Registry
- Status
- RECRUITING
- Phase
- N/A
Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis
- Status
- RECRUITING
- Phase
- PHASE3
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
- Status
- RECRUITING
- Phase
- PHASE2
Home Reported Outcomes in PNH
- Status
- RECRUITING
- Phase
- N/A
A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Real-world, Multi-center, Prospective, Observational Study for PNH in China
- Status
- COMPLETED
- Phase
- N/A
Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE1
Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE2
Compassionate Use of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Danicopan Early Access Program
- Status
- AVAILABLE
- Phase
- N/A
Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- COMPLETED
- Phase
- PHASE1
Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China
- Status
- COMPLETED
- Phase
- PHASE3
Hematological Response in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5 Antibody: an External Control Arm Study for Iptacopan Use in Anti-C5 naïve Patients
- Status
- COMPLETED
- Phase
- N/A
Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1